Safer Way Developed To Use Warfarin
3/02/2012
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States...
Selenium Supplements May Harm Not Help
3/01/2012
According to a recent study, published Online First in The Lancet , selenium may help people who don't have enough of it, but for the people who have enough to begin with, selenium supplements may be detrimental to their health. It is shown in the study that taking the supplements may result in the development of type 2 diabetes...
Breast Cancer Repeat Surgery Less Likely If Pathologist Present During First Operation
3/01/2012
T he American Cancer Society estimates that this year alone, 229,060 Americans will be diagnosed with breast cancer and 39,920 patients will die from the disease. Almost one in three women with breast cancer surgery will require additional surgery, following a pathologic examination of their tumor...
Breast Cancer Repeat Surgery Less Likely If Pathologist Present During First Operation
3/01/2012
T he American Cancer Society estimates that this year alone, 229,060 Americans will be diagnosed with breast cancer and 39,920 patients will die from the disease. Almost one in three women with breast cancer surgery will require additional surgery, following a pathologic examination of their tumor...
TREM Rx, Inc...
Symptoms Of Myelofibrosis Relieved By Ruxolitinib
3/01/2012
People with a blood cancer - myelofibrosis - can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine...
Symptoms Of Myelofibrosis Relieved By Ruxolitinib
3/01/2012
People with a blood cancer - myelofibrosis - can benefit from a drug called ruxolitinib, according to a randomized, double-blind, placebo-controlled clinical trial that included patients and researchers from the Stanford University School of Medicine...
Potential Solution To Melanoma's Resistance To Vemurafenib
3/01/2012
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma. Vemurafenib resistance is characterized by a diminished apoptosis (programmed cancer cell death) response...
Nurses Key In Helping New Cancer Patients Overcome Fears
3/01/2012
Often faced with overwhelming anxiety, patients newly diagnosed with lung cancer can find themselves in distress, and new research recommends nurses play a key role in alleviating concerns, leading to a better quality of life for patients...
Sleeping Pills Linked To Death And Cancer Risk
3/01/2012
According to a study published in the online journal BMJ Open, some well-known sleeping medications have an elevated risk of death, even when taken only 18 times a year, and an increased risk of death when taken in large numbers. To determine their findings, the researchers analyzed survival rates of 10,500 volunteers who were taking sleeping pills for an average of 2...